|
|
Volumn 326, Issue 7400, 2003, Pages 1213-
|
|
Shared scheme for assessing drugs for multiple sclerosis: why are eyes tightly shut to considering causes other than autoimmunity?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
GLATIRAMER;
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
PEPTIDE;
CLINICAL TRIAL;
ECONOMICS;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
ADJUVANTS, IMMUNOLOGIC;
CLINICAL TRIALS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
PEPTIDES;
|
|
EID: 0038748147
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.326.7400.1213 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
